Skip to content
Home/Companies/Biotech/Navinci Diagnostics

Navinci Diagnostics

Biotech·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Navinci Diagnostics?

Navinci Diagnostics is a Swedish Biotech company, currently owned by Segulah Medical Acceleration since 2022.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Segulah Medical Acceleration
Investor
Segulah Medical Acceleration
Segulah Medical Acceleration · 2021 · Life Sciences VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Segulah Medical Acceleration

Other portfolio companies in the same fund.

Basic Genomics
Active
BiotechSweden· 2025
Protembis
Protembis
Active
MedTechGermany· 2024
Collective Minds Radiology
Active
HealthTechSweden· 2023
Senzime
Active
MedTechSweden· 2023
CytaCoat
Active
MedTechSweden· 2021
Quanta Dialysis Technologies
Quanta Dialysis Technologies
Active
MedTechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Navinci Diagnostics?

Navinci Diagnostics is currently owned by Segulah Medical Acceleration, through Segulah Medical Acceleration, since 2022.

When did Segulah Medical Acceleration acquire Navinci Diagnostics?

Segulah Medical Acceleration acquired Navinci Diagnostics in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue